These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26908458)

  • 1. ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.
    Schlienger S; Campbell S; Pasquin S; Gaboury L; Claing A
    Oncotarget; 2016 Mar; 7(13):15811-27. PubMed ID: 26908458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1.
    Xie X; Tang SC; Cai Y; Pi W; Deng L; Wu G; Chavanieu A; Teng Y
    Oncotarget; 2016 Sep; 7(36):58111-58120. PubMed ID: 27517156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.
    Schlienger S; Ramirez RA; Claing A
    Cell Signal; 2015 Mar; 27(3):403-15. PubMed ID: 25530216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance.
    Tsai MM; Lin PY; Cheng WL; Tsai CY; Chi HC; Chen CY; Tseng YH; Cheng YF; Chen CD; Liang Y; Liao CJ; Wu SM; Lin YH; Chung IH; Wang CS; Lin KH
    Cancer Sci; 2012 Jun; 103(6):1136-44. PubMed ID: 22348287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells.
    Boulay PL; Cotton M; Melançon P; Claing A
    J Biol Chem; 2008 Dec; 283(52):36425-34. PubMed ID: 18990689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells.
    Lewis-Saravalli S; Campbell S; Claing A
    Cell Signal; 2013 Sep; 25(9):1813-9. PubMed ID: 23707487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
    Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H
    Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein.
    Boulay PL; Schlienger S; Lewis-Saravalli S; Vitale N; Ferbeyre G; Claing A
    Oncogene; 2011 Sep; 30(36):3846-61. PubMed ID: 21478909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors.
    Haines E; Schlienger S; Claing A
    Cancer Biol Ther; 2015; 16(10):1535-47. PubMed ID: 26176330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARNP, a participant in mRNA splicing and export, negatively regulates E-cadherin expression via interaction with pinin.
    Kang GJ; Park MK; Byun HJ; Kim HJ; Kim EJ; Yu L; Kim B; Shim JG; Lee H; Lee CH
    J Cell Physiol; 2020 Feb; 235(2):1543-1555. PubMed ID: 31313837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion.
    Schlienger S; Campbell S; Claing A
    Mol Biol Cell; 2014 Jan; 25(1):17-29. PubMed ID: 24196838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
    Liu J; Chen X; Ward T; Pegram M; Shen K
    Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.
    Davis JE; Xie X; Guo J; Huang W; Chu WM; Huang S; Teng Y; Wu G
    Oncotarget; 2016 Jun; 7(26):39834-39845. PubMed ID: 27213581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM
    Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
    Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
    Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer.
    Srinivasan A; Thangavel C; Liu Y; Shoyele S; Den RB; Selvakumar P; Lakshmikuttyamma A
    Mol Carcinog; 2016 May; 55(5):743-56. PubMed ID: 25968914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
    Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
    Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.